Capillarys Neonat HB (Pn 2006)
Abnormal Hemoglobin Quantitation. 510(k) K091283, from Sebia (Norcross, GA). Product code GKA, class 2.
As of Nov 20, 2026, K091283 is an FDA 510(k) held by Sebia, substantially equivalent on Feb 22, 2010 after 297 days, with no recalls tied to it in FDA's recall database.
- Review time: 297 days
- Recalls: 0
- Cited as a predicate by: 1 device
The CAPILLARYS NEONAT Hb kit is designed for the separation of the normal hemoglobins (F and A) in blood samples from human new-borns, and for the detection of the major hemoglobin variants (S, C, E, D and Bart's), by electrophoresis in alkaline buffer (pH 9.4) with the CAPILLARYS 2 System. The CAPILLARYS NEONAT Hb kit is designed for laboratory use.
- CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS InstrumentK232027 · Sebia · Apr 4, 2024
- CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS InstrumentK232027 · Sebia · Apr 4, 2024
- Premier Resolution SystemK222635 · Trinity Biotech (Primus Corporation, Dba Trinity Biotech) · Aug 4, 2023
- V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo ControlK192931 · Helena Laboratories, Corp. · Apr 19, 2022
- Type
- Traditional
- Received
- May 1, 2009
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7415
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files